Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06452 | 32877688 | Cell Metab | Not Chopped Liver-A Careful, Fate-Mapping Study of Macrophages in NASH. | 2020 | Details |
| A06453 | 32877569 | Clin Infect Dis | Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection. | 2021 | Details |
| A06454 | 32877213 | Am J Physiol Gastrointest Liver Physiol | High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis. | 2020 | Details |
| A06455 | 32876312 | Rev Paul Pediatr | THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW. | 2020 | Details |
| A06457 | 32875543 | J Physiol Biochem | Metabolite profiling of mice under long-term fructose drinking and vitamin D deficiency: increased risks for metabolic syndrome and nonalcoholic fatty liver disease. | 2020 | Details |
| A06458 | 32874784 | PeerJ | Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A06459 | 32872474 | Pharmaceuticals (Basel) | Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. | 2020 | Details |
| A06460 | 32872238 | Nutrients | Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06461 | 32872090 | Diagnostics (Basel) | An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials. | 2020 | Details |
| A06462 | 32871978 | Medicine (Baltimore) | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes. | 2020 | Details |
| A06463 | 32870526 | J Gastroenterol Hepatol | Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model. | 2020 | Details |
| A06466 | 32869884 | J Food Biochem | Remedial role of exercise training to deep-fried oil-induced metabolic and histological changes in Wistar rats. | 2020 | Details |
| A06467 | 32868684 | Curr Opin Clin Nutr Metab Care | Dietary protein intake and obesity-associated cardiometabolic function. | 2020 | Details |
| A06468 | 32868653 | Eur J Gastroenterol Hepatol | Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. | 2021 | Details |
| A06469 | 32868652 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. | 2021 | Details |
| A06470 | 32867573 | J Histochem Cytochem | 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept. | 2020 | Details |
| A06471 | 32867260 | Medicina (Kaunas) | Probiotics: Versatile Bioactive Components in Promoting Human Health. | 2020 | Details |
| A06472 | 32866186 | PLoS One | Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. | 2020 | Details |
| A06473 | 32865925 | Int J Med Mushrooms | Pharmacological Investigation of Ceraceomyces tessulatus (Agaricomycetes) in Mice with Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06474 | 32865911 | Crit Rev Oncog | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression. | 2020 | Details |
| A06475 | 32865597 | Diabetologia | Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). | 2020 | Details |
| A06477 | 32864415 | Alzheimers Dement (N Y) | Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging. | 2020 | Details |
| A06478 | 32863955 | Theranostics | Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. | 2020 | Details |
| A06479 | 32863886 | BioData Min | Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06480 | 32863329 | Tohoku J Exp Med | Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study. | 2020 | Details |
| A06481 | 32863214 | Redox Biol | Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. | 2020 | Details |
| A06482 | 32863213 | Redox Biol | Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. | 2020 | Details |
| A06483 | 32862731 | Int J Food Sci Nutr | Dietary calamondin supplementation slows the progression of non-alcoholic fatty liver disease in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A06484 | 32862405 | Endocrine | PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide. | 2020 | Details |
| A06485 | 32861753 | Gastrointest Endosc | Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. | 2020 | Details |
| A06486 | 32860311 | Liver Int | The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men. | 2021 | Details |
| A06487 | 32859881 | Chin J Physiol | Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver disease. | 2020 | Details |
| A06488 | 32859329 | Clin Nutr ESPEN | The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. | 2020 | Details |
| A06490 | 32857176 | Eur J Nutr | Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study. | 2020 | Details |
| A06491 | 32856978 | J Med Food | Fisetin Alleviates Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice. | 2020 | Details |
| A06492 | 32856322 | J Pharm Pharmacol | Therapeutic effects of açaí seed extract on hepatic steatosis in high-fat diet-induced obesity in male mice: a comparative effect with rosuvastatin. | 2020 | Details |
| A06493 | 32856188 | Eur J Nutr | Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study. | 2020 | Details |
| A06495 | 32853691 | Diabetes Res Clin Pract | Development and validation of screening scores of non-alcoholic fatty liver disease in middle-aged and elderly Chinese. | 2020 | Details |
| A06496 | 32853678 | J Nutr Biochem | N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1. | 2020 | Details |
| A06498 | 32852705 | J Endocrinol Invest | Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease. | 2020 | Details |
| A06499 | 32851764 | Liver Int | Health related quality of life in chronic liver diseases. | 2020 | Details |
| A06500 | 32850919 | Front Med (Lausanne) | Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea. | 2020 | Details |
| A06501 | 32850903 | Front Med (Lausanne) | Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. | 2020 | Details |
| A06502 | 32850884 | Front Med (Lausanne) | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD. | 2020 | Details |
| A06503 | 32849935 | J Clin Med Res | Non-Alcoholic Fatty Liver Disease Modifies Serum Gamma-Glutamyl Transferase in Cigarette Smokers. | 2020 | Details |
| A06504 | 32849904 | Evid Based Complement Alternat Med | Si-Wu-Tang Alleviates Nonalcoholic Fatty Liver Disease via Blocking TLR4-JNK and Caspase-8-GSDMD Signaling Pathways. | 2020 | Details |
| A06505 | 32849604 | Front Immunol | Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice. | 2020 | Details |
| A06506 | 32849314 | Front Endocrinol (Lausanne) | Fructose Consumption During Pregnancy Influences Milk Lipid Composition and Offspring Lipid Profiles in Guinea Pigs. | 2020 | Details |
| A06507 | 32849291 | Front Endocrinol (Lausanne) | Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD. | 2020 | Details |
| A06508 | 32849284 | Front Endocrinol (Lausanne) | Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. | 2020 | Details |
| A06509 | 32849276 | Front Endocrinol (Lausanne) | Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases. | 2020 | Details |
| A06510 | 32848877 | Front Physiol | Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation. | 2020 | Details |
| A06511 | 32848838 | Front Physiol | Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease. | 2020 | Details |
| A06512 | 32848718 | Front Pharmacol | Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders. | 2020 | Details |
| A06513 | 32848374 | Clin Interv Aging | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population. | 2020 | Details |
| A06514 | 32847841 | BMJ Open Diabetes Res Care | Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes. | 2020 | Details |
| A06515 | 32846929 | Nutrients | A Traditional Korean Diet Alters the Expression of Circulating MicroRNAs Linked to Diabetes Mellitus in a Pilot Trial. | 2020 | Details |
| A06516 | 32846589 | Food Res Int | Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome. | 2020 | Details |
| A06517 | 32845887 | PLoS One | Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study. | 2020 | Details |
| A06518 | 32845234 | Med Decis Making | Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis. | 2020 | Details |
| A06519 | 32843301 | Sleep Med | Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis. | 2020 | Details |
| A06520 | 32843283 | J Diabetes Complications | Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06522 | 32841505 | Liver Int | Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. | 2020 | Details |
| A06523 | 32841326 | J Clin Endocrinol Metab | Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis. | 2020 | Details |
| A06524 | 32841307 | PLoS One | Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program. | 2020 | Details |
| A06525 | 32841140 | Medicina (B Aires) | [Diagnosis and treatment of non-alcoholic fatty liver disease. Argentine Association for the Study of Liver Diseases, year 2019]. | 2020 | Details |
| A06526 | 32840963 | Liver Int | The association of low-grade albuminuria with incident non-alcoholic fatty liver disease and non-invasive markers of liver fibrosis by glycaemia status. | 2021 | Details |
| A06527 | 32840311 | J Clin Endocrinol Metab | Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06528 | 32839596 | Nat Metab | Fructose stimulated de novo lipogenesis is promoted by inflammation. | 2020 | Details |
| A06529 | 32839409 | Biomedicines | Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06530 | 32839076 | Eur J Intern Med | Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study. | 2020 | Details |
| A06531 | 32838396 | MedComm (2020) | Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia. | 2020 | Details |
| A06532 | 32838108 | Hepatol Commun | Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06533 | 32836224 | Dig Dis | Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. | 2020 | Details |
| A06534 | 32835190 | JHEP Rep | Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. | 2020 | Details |
| A06535 | 32833701 | Curr Opin Clin Nutr Metab Care | Lifestyle interventions affecting hepatic fatty acid metabolism. | 2020 | Details |
| A06536 | 32833552 | J Med Food | Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China. | 2020 | Details |
| A06537 | 32833053 | Langenbecks Arch Surg | Mechanisms of nonalcoholic fatty liver disease and implications for surgery. | 2020 | Details |
| A06538 | 32833043 | Arch Toxicol | A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats. | 2020 | Details |
| A06539 | 32832560 | J Diabetes Res | The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A06542 | 32832491 | Can J Gastroenterol Hepatol | Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. | 2020 | Details |
| A06543 | 32832402 | J Clin Transl Hepatol | NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. | 2020 | Details |
| A06544 | 32832391 | J Clin Transl Hepatol | Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise. | 2020 | Details |
| A06545 | 32831555 | J Family Community Med | Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. | 2020 | Details |
| A06546 | 32831531 | Med Chem Res | Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity. | 2020 | Details |
| A06547 | 32830817 | J Gastrointestin Liver Dis | Non-alcoholic Steatohepatitis: Comparison of Intestinal Microbiota between Different Metabolic Profiles. A Pilot Study. | 2020 | Details |
| A06548 | 32829997 | J Diabetes Complications | NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. | 2020 | Details |
| A06550 | 32829576 | Ann Lab Med | Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases. | 2020 | Details |
| A06551 | 32828745 | Clin Res Hepatol Gastroenterol | Myosteatosis in nonalcoholic fatty liver disease: An exploratory study. | 2020 | Details |
| A06552 | 32827918 | Int Immunopharmacol | Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway. | 2020 | Details |
| A06553 | 32827432 | J Clin Endocrinol Metab | Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06554 | 32826226 | Br J Sports Med | Association of physical activity with risk of hepatobiliary diseases in China: a prospective cohort study of 0.5 million people. | 2020 | Details |
| A06555 | 32825982 | J Bodyw Mov Ther | Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease. | 2020 | Details |
| A06556 | 32825885 | Indian J Tuberc | An unique case report: Unusual presentation of mediastinal lymph node tuberculosis in an adult. | 2020 | Details |
| A06557 | 32825458 | J Clin Med | Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06558 | 32825440 | Int J Mol Sci | Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review. | 2020 | Details |
| A06559 | 32825154 | Nutrients | The Protective Effect of Myristica fragrans Houtt. Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06560 | 32824744 | Int J Mol Sci | Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury. | 2020 | Details |
| A06561 | 32824723 | Int J Mol Sci | Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options. | 2020 | Details |